Valurx Dye Free Allergy Relief Capsule, Liquid Filled
NDC Package 83059-0080-1
Package Information
Valurx Dye Free Allergy Relief (diphenhydramine hci 25 mg) capsules is take every 4 to 6 hours, or as directed by a doctordo not take more than 6 times in 24 hours adults and children 12 years and over1 to 2 softgelschildren 6 to under 12 years1 softgelchildren under 6 years do not use. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Shield Pharmaceuticals Corp, this product is identified by NDC 83059-0080 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1049909 - diphenhydrAMINE HCl 25 MG Oral Capsule
- RxCUI: 1049909 - diphenhydramine hydrochloride 25 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 83059 - Shield Pharmaceuticals Corp
- 83059-0080 - Valurx Dye Free Allergy Relief
- 83059-0080-1 - 1 BOTTLE in 1 BOX / 12 CAPSULE, LIQUID FILLED in 1 BOTTLE
- 83059-0080 - Valurx Dye Free Allergy Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83059-0080-1 identifies a specific commercial package of 1 bottle in 1 box / 12 capsule, liquid filled in 1 bottle of Valurx Dye Free Allergy Relief, a human over the counter drug labeled by Shield Pharmaceuticals Corp. This capsule, liquid filled is formulated for oral use and contains diphenhydramine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Shield Pharmaceuticals Corp on February 17, 2025. The current certification is valid through December 31, 2026.
How is this Shield Pharmaceuticals Corp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83059008001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.